Anuh Pharma Ltd: Fundamental Analysis, Share Price Insights & Intrinsic Value (2024)

Share Price and Basic Stock Data

Last Updated: December 21, 2024, 1:26 am

Market Cap	1,117 Cr.
Current Price	223
High / Low	265/146
Stock P/E	18.9
Book Value	60.5
Dividend Yield	1.12 %
ROCE	25.6 %
ROE	19.5 %
Face Value	5.00
PEG Ratio	1.24

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for

Competitors of

Stock Name	Market Cap	Current Price	High / Low	Stock P/E	Book Value	Dividend Yield	ROCE	ROE	Face Value
Gujarat Themis Biosyn Ltd	3,354 Cr.	308	390/128	63.6	20.5	0.22 %	45.0 %	33.8 %	1.00
Gujarat Terce Laboratories Ltd	62.6 Cr.	84.4	94.9/26.6	24.0	11.9	0.00 %	9.72 %	3.44 %	10.0
Gujarat Inject (Kerala) Ltd	35.9 Cr.	24.5	24.5/8.74	46.6	6.64	0.00 %	2.65 %	2.08 %	10.0
Godavari Drugs Ltd	86.7 Cr.	115	155/87.0	13.0	55.4	0.00 %	14.4 %	15.5 %	10.0
Glenmark Life Sciences Ltd	12,416 Cr.	1,013	1,335/645	29.3	207	2.22 %	28.1 %	21.1 %	2.00
Industry Average	14,994.84	N/A		46.07	N/A	N/A	16.07	15.77	N/A

All Competitor Stocks of

Quarterly Result

Month	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
Sales	117.27	108.74	131.66	128.97	116.38	115.07	138.73	157.31	161.48	149.53	172.10	163.89	137.91
Expenses	108.90	96.26	119.52	115.10	105.20	101.64	126.30	143.08	147.51	131.57	148.11	144.67	127.34
Operating Profit	8.37	12.48	12.14	13.87	11.18	13.43	12.43	14.23	13.97	17.96	23.99	19.22	10.57
OPM %	7.14%	11.48%	9.22%	10.75%	9.61%	11.67%	8.96%	9.05%	8.65%	12.01%	13.94%	11.73%	7.66%
Other Income	1.92	1.91	0.34	1.03	0.96	2.01	2.11	1.04	3.47	2.15	3.66	2.82	3.72
Interest	0.18	0.39	0.58	-0.18	0.06	0.11	0.03	0.02	0.02	0.09	0.14	0.10	0.14
Depreciation	2.99	2.97	2.99	3.01	2.42	2.44	2.43	2.41	2.01	2.15	2.20	2.23	1.88
Profit before tax	7.12	11.03	8.91	12.07	9.66	12.89	12.08	12.84	15.41	17.87	25.31	19.71	12.27
Tax %	21.35%	22.12%	16.39%	26.01%	24.12%	23.04%	22.93%	25.08%	23.75%	22.61%	24.46%	22.12%	22.49%
Net Profit	5.59	8.60	7.45	8.93	7.34	9.92	9.31	9.62	11.75	13.83	19.11	15.36	9.51
EPS in Rs	1.12	1.72	1.49	1.78	1.46	1.98	1.86	1.92	2.34	2.76	3.81	3.07	1.90

Last Updated: October 7, 2024, 8:39 am

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: Unknown

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM
Sales	243	266	284	326	206	238	321	307	432	487	527	647	623
Expenses	225	242	253	289	183	220	291	284	387	439	476	571	552
Operating Profit	18	24	31	38	23	18	30	23	45	47	52	76	72
OPM %	7%	9%	11%	12%	11%	8%	9%	8%	10%	10%	10%	12%	12%
Other Income	2	4	5	4	8	7	5	4	11	5	6	12	12
Interest	1	1	1	1	1	0	1	1	2	2	1	1	0
Depreciation	2	2	3	2	2	2	2	7	15	12	10	9	8
Profit before tax	18	25	32	38	28	23	32	19	39	39	47	78	75
Tax %	29%	31%	31%	32%	27%	29%	28%	25%	26%	22%	24%	23%
Net Profit	13	18	22	26	20	17	23	14	28	31	36	60	58
EPS in Rs	2.50	3.51	4.39	5.15	4.00	3.30	4.66	2.86	5.68	6.10	7.22	11.99	11.54
Dividend Payout %	40%	37%	27%	24%	31%	42%	29%	48%	26%	29%	28%	21%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2013-2014	2014-2015	2015-2016	2016-2017	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024
YoY Net Profit Growth (%)	38.46%	22.22%	18.18%	-23.08%	-15.00%	35.29%	-39.13%	100.00%	10.71%	16.13%	66.67%
Change in YoY Net Profit Growth (%)	0.00%	-16.24%	-4.04%	-41.26%	8.08%	50.29%	-74.42%	139.13%	-89.29%	5.41%	50.54%

has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2013-2014 to 2023-2024.

Growth

Compounded Sales Growth
10 Years:	9%
5 Years:	15%
3 Years:	14%
TTM:	5%

Compounded Profit Growth
10 Years:	12%
5 Years:	19%
3 Years:	32%
TTM:	33%

Stock Price CAGR
10 Years:	15%
5 Years:	29%
3 Years:	30%
1 Year:	49%

Return on Equity
10 Years:	15%
5 Years:	14%
3 Years:	16%
Last Year:	19%

Last Updated: Unknown

Balance Sheet

Last Updated: November 14, 2024, 5:52 pm

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Sep 2024
Equity Capital	4	4	4	13	13	13	13	13	25	25	25	25	25
Reserves	71	82	97	107	128	137	152	150	166	189	216	266	278
Borrowings	1	0	0	2	0	2	4	45	14	4	1	3	14
Other Liabilities	60	77	67	71	48	57	71	119	128	129	163	152	117
Total Liabilities	136	163	168	193	189	209	240	326	333	347	405	446	434
Fixed Assets	10	12	9	18	17	17	21	84	71	61	53	49	46
CWIP	3	0	0	0	0	6	34	0	0	0	0	0	2
Investments	19	27	43	43	70	66	39	80	31	43	91	97	98
Other Assets	104	124	116	131	101	120	147	163	230	243	261	300	288
Total Assets	136	163	168	193	189	209	240	326	333	347	405	446	434

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Cash from Operating Activity +	2	15	19	16	26	2	7	49	-19	29	54	13
Cash from Investing Activity +	4	-5	-12	-5	-20	2	3	-77	52	-8	-43	1
Cash from Financing Activity +	-6	-8	-8	-9	-4	-5	-7	22	-33	-19	-12	-9
Net Cash Flow	-0	2	-1	2	2	-1	3	-5	0	2	-2	5

Free Cash Flow

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Free Cash Flow	17.00	24.00	31.00	36.00	23.00	16.00	26.00	-22.00	31.00	43.00	51.00	73.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	82	102	88	84	100	109	85	96	90	102	118	107
Inventory Days	43	33	27	35	72	64	64	98	90	77	66	57
Days Payable	86	102	79	77	102	105	89	166	133	117	139	105
Cash Conversion Cycle	39	33	36	42	70	68	61	28	48	62	46	58
Working Capital Days	45	42	43	51	79	83	70	44	68	70	61	68
ROCE %	26%	31%	33%	35%	19%	14%	19%	10%	16%	18%	19%	26%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Promoters	70.43%	70.59%	70.59%	70.59%	70.59%	70.59%	70.59%	69.94%	69.91%	69.91%	69.91%	69.91%
FIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.03%	0.03%	0.02%	0.02%
DIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.10%	0.00%	0.00%	0.00%
Public	29.56%	29.42%	29.41%	29.40%	29.40%	29.39%	29.40%	30.05%	29.96%	30.05%	30.06%	30.06%
No. of Shareholders	21,123	20,740	20,452	20,470	19,969	19,423	19,066	20,519	22,237	23,494	23,910	24,048

Shareholding Pattern Chart

No. of Shareholders

This stock is not held by any mutual fund

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
FaceValue	5.00	5.00	5.00	5.00	5.00
Basic EPS (Rs.)	11.98	7.22	6.10	5.67	5.71
Diluted EPS (Rs.)	11.98	7.22	6.10	5.67	5.71
Cash EPS (Rs.)	13.70	9.15	8.48	8.68	8.52
Book Value[Excl.RevalReserv]/Share (Rs.)	58.11	48.14	42.66	38.04	64.74
Book Value[Incl.RevalReserv]/Share (Rs.)	58.11	48.14	42.66	38.04	64.74
Dividend / Share (Rs.)	2.50	2.00	1.75	1.50	2.75
Revenue From Operations / Share (Rs.)	129.11	105.26	97.11	86.20	122.51
PBDIT / Share (Rs.)	17.41	11.45	10.39	11.00	10.77
PBIT / Share (Rs.)	15.70	9.52	8.00	7.99	7.96
PBT / Share (Rs.)	15.63	9.47	7.81	7.69	7.64
Net Profit / Share (Rs.)	11.98	7.22	6.10	5.67	5.71
PBDIT Margin (%)	13.48	10.87	10.69	12.76	8.78
PBIT Margin (%)	12.15	9.04	8.23	9.27	6.49
PBT Margin (%)	12.10	8.99	8.03	8.92	6.24
Net Profit Margin (%)	9.28	6.85	6.27	6.58	4.66
Return on Networth / Equity (%)	20.62	14.99	14.29	14.91	8.81
Return on Capital Employeed (%)	26.84	19.57	18.53	20.73	12.18
Return On Assets (%)	13.47	8.93	8.80	8.54	4.38
Total Debt / Equity (X)	0.01	0.00	0.01	0.07	0.27
Asset Turnover Ratio (%)	1.52	1.40	1.43	1.31	1.08
Current Ratio (X)	2.20	1.91	1.98	1.70	1.37
Quick Ratio (X)	1.71	1.46	1.37	1.12	0.99
Inventory Turnover Ratio (X)	6.62	4.94	4.36	4.53	4.59
Dividend Payout Ratio (NP) (%)	16.68	24.23	24.59	0.00	96.33
Dividend Payout Ratio (CP) (%)	14.60	19.11	17.67	0.00	64.58
Earning Retention Ratio (%)	83.32	75.77	75.41	0.00	3.67
Cash Earning Retention Ratio (%)	85.40	80.89	82.33	0.00	35.42
Interest Coverage Ratio (X)	246.74	262.77	54.16	36.88	34.06
Interest Coverage Ratio (Post Tax) (X)	170.85	166.66	32.80	20.03	19.06
Enterprise Value (Cr.)	1223.09	392.34	417.88	446.02	334.07
EV / Net Operating Revenue (X)	1.89	0.74	0.85	1.03	1.09
EV / EBITDA (X)	14.02	6.84	8.03	8.09	12.38
MarketCap / Net Operating Revenue (X)	1.90	0.75	0.88	1.05	0.95
Retention Ratios (%)	83.31	75.76	75.40	0.00	3.66
Price / BV (X)	4.23	1.65	2.01	2.37	1.80
Price / Net Operating Revenue (X)	1.90	0.75	0.88	1.05	0.95
EarningsYield	0.04	0.09	0.07	0.06	0.04

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of as of December 22, 2024 is: 225.47

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of December 22, 2024, is Undervalued by 1.11% compared to the current share price 223.00

Intrinsic Value of as of December 22, 2024 is: 259.81

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of December 22, 2024, is Undervalued by 16.51% compared to the current share price 223.00

Last 5 Year EPS CAGR: 15.23%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The stock has a high average ROCE of 22.17%, which is a positive sign. The company has higher reserves (156.85 cr) compared to borrowings (6.92 cr), indicating strong financial stability. The company has shown consistent growth in sales (377.46 cr) and profit (37.92 cr) over the years.	The stock has a high average Working Capital Days of 60.33, which may not be favorable. The stock has a high average Cash Conversion Cycle of 49.25, which may not be favorable.

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in :
1. Net Profit Margin: 9.28%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 26.84% (Industry Average ROCE: 16.07%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 20.62% (Industry Average ROE: 15.77%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 170.85
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 1.71
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 18.9 (Industry average Stock P/E: 46.07)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0.01
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

Anuh Pharma Ltd. is a Public Limited Listed company incorporated on 19/02/1960 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24230MH1960PLC011586 and registration number is 011586. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 486.65 Cr. and Equity Capital is Rs. 25.06 Cr. for the Year ended 31/03/2022.

INDUSTRY	ADDRESS	CONTACT
Pharmaceuticals	3-A, Shivsagar Estate, Mumbai Maharashtra 400018	anuh@sk1932.com http://www.anuhpharma.com

Management
Name	Position Held
Mr. Arun Todarwal	Chairman & Non-Exe.Director
Mr. Bipin N Shah	Vice Chairman
Mr. Ritesh B Shah	Joint Managing Director
Mr. Vivek B Shah	Joint Managing Director
Mr. Sandeep Joshi	Independent Director
Mr. Harmanbhai Patel	Independent Director
Dr.(Ms.) Mita Dixit	Independent Director
Mr. Siddharth J Shah	Independent Director
Mr. Pradeep H Thakur	Independent Director
Mr. Ketan Shah	Non Executive Director
Mr. Bharat Shah	Non Executive Director
Mr. Samir Shah	Non Executive Director
Mr. Gaurav S Shah	Non Executive Director

FAQ

What is the latest intrinsic value of ?

The latest intrinsic value of as on 22 December 2024 is ₹225.47, which is 1.11% higher than the current market price of ₹223.00. The stock has a market capitalization of 1,117 Cr. and recorded a high/low of 265/146 during the current fiscal year 2024-2025. As of Sep 2024, the company has reserves of ₹278 Cr and total liabilities of ₹434 Cr.

What is the Market Cap of ?

The Market Cap of is 1,117 Cr..

What is the current Stock Price of as on 22 December 2024?

The current stock price of as on 22 December 2024 is 223.

What is the High / Low of stocks in FY 2024-2025?

In FY 2024-2025, the High / Low of stocks is 265/146.

What is the Stock P/E of ?

The Stock P/E of is 18.9.

What is the Book Value of ?

The Book Value of is 60.5.

What is the Dividend Yield of ?

The Dividend Yield of is 1.12 %.

What is the ROCE of ?

The ROCE of is 25.6 %.

What is the ROE of ?

The ROE of is 19.5 %.

What is the Face Value of ?

The Face Value of is 5.00.